Search details
1.
Effects of Serelaxin in Patients with Acute Heart Failure.
N Engl J Med
; 381(8): 716-726, 2019 08 22.
Article
in English
| MEDLINE | ID: mdl-31433919
2.
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial.
Blood Press
; 28(2): 77-83, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30614275
3.
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
Eur Heart J
; 39(24): 2243-2251, 2018 06 21.
Article
in English
| MEDLINE | ID: mdl-29365085
4.
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.
Am Heart J
; 187: 62-69, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28454809
5.
Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
J Card Fail
; 23(1): 63-71, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27825893
6.
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
Eur Heart J
; 37(12): 955-64, 2016 Mar 21.
Article
in English
| MEDLINE | ID: mdl-26590384
7.
Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
Blood Press
; 25(4): 235-40, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-26808585
8.
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Blood Press
; 25(2): 83-92, 2016.
Article
in English
| MEDLINE | ID: mdl-26511535
9.
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF.
Eur Heart J
; 34(40): 3128-36, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23999454
10.
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Eur Heart J
; 34(40): 3117-27, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23999456
11.
Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack.
J Stroke Cerebrovasc Dis
; 23(10): 2814-2818, 2014.
Article
in English
| MEDLINE | ID: mdl-25304725
12.
Effect of nateglinide on the incidence of diabetes and cardiovascular events.
N Engl J Med
; 362(16): 1463-76, 2010 Apr 22.
Article
in English
| MEDLINE | ID: mdl-20228402
13.
Effect of valsartan on the incidence of diabetes and cardiovascular events.
N Engl J Med
; 362(16): 1477-90, 2010 Apr 22.
Article
in English
| MEDLINE | ID: mdl-20228403
14.
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
JAMA
; 309(11): 1125-35, 2013 Mar 20.
Article
in English
| MEDLINE | ID: mdl-23478743
15.
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
Kidney Int
; 81(6): 568-76, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22189843
16.
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
Blood Press
; 21(2): 82-7, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-21830844
17.
Determining the most appropriate components for a composite clinical trial outcome.
Am Heart J
; 156(4): 633-40, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18926145
18.
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
J Hypertens
; 26(3): 403-11, 2008 Mar.
Article
in English
| MEDLINE | ID: mdl-18300848
19.
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.
Int J Cardiol
; 253: 91-96, 2018 02 15.
Article
in English
| MEDLINE | ID: mdl-29306479
20.
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
J Hypertens
; 25(7): 1473-9, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17563571